A manufacturing method of a perovskite film and a composition for preparing the perovskite film. The manufacturing method of the perovskite film comprises a step of manufacturing a first mixed solution, a step of manufacturing a second mixed solution, a low pressure distillation step, a coating step, and a drying step. The technical effect of the present disclosure is to provide the manufacturing method of the perovskite film and the composition for manufacturing the perovskite film, wherein the perovskite film comprises components of a metal halide and an organic halogen salt to adjust absorption wavelengths and emission wavelengths by modulating components and concentration of each component and makes the perovskite film have a higher transmittance in the visible light band. When ultraviolet light illuminates the perovskite film, the perovskite film can produce visible light due to photoluminescence effect of the perovskite material in the perovskite film, thereby achieving display effect.

The invention relates to a crystalline form of lamotrigine hydrate, a method for preparing the same and a composition comprising the same, and in particular, to a lamotrigine hydrate form A, a method for preparing the lamotrigine hydrate form A and a composition comprising the lamotrigine hydrate form A.

The invention relates to a crystalline form of lamotrigine hydrate, a method for preparing the same and a composition comprising the same, and in particular, to a lamotrigine hydrate form A, a method for preparing the lamotrigine hydrate form A and a composition comprising the lamotrigine hydrate form A.

The present invention describes a process to isomerize industrial hemp derived Cannabidiol (CBD) to a pure Δ8-tetrahydrocannabinol (Δ8-THC) extract. This procedure will produce Δ8-tetrahydrocannabinol that is essentially free from any detectable levels of Δ9-tetrahydrocannabinol (Δ9-THC). Included in this filing are methods and processes to scale the reaction from the lab to process to large scale manufacturing. Additionally, the resulting extract from said methods and processes consists of higher purity than previously reported in the art and greater efficiency compared to prior art.

The present invention describes a process to isomerize industrial hemp derived Cannabidiol (CBD) to a pure Δ8-tetrahydrocannabinol (Δ8-THC) extract. This procedure will produce Δ8-tetrahydrocannabinol that is essentially free from any detectable levels of Δ9-tetrahydrocannabinol (Δ9-THC). Included in this filing are methods and processes to scale the reaction from the lab to process to large scale manufacturing. Additionally, the resulting extract from said methods and processes consists of higher purity than previously reported in the art and greater efficiency compared to prior art.

The present invention relates to a method for producing an aldehyde by a hydroformylation reaction of reacting an olefin with hydrogen and carbon monoxide in the presence of a Group 8 to 10 metal-phosphine complex catalyst, including the following steps (1) and (2): (1) a step of oxidizing by withdrawing a reaction solution having accumulated therein a high-boiling-point byproduct from a reaction zone and bringing the withdrawn reaction solution into contact with an oxygen-containing gas, and (2) a step of, after the step (1), mixing a poor solvent and hydrogen with the reaction solution, then crystallizing the Group 8 to 10 metal-phosphine complex catalyst by crystallization, and recovering the crystallized complex catalyst from the reaction solution.

The present invention relates to a method for producing an aldehyde by a hydroformylation reaction of reacting an olefin with hydrogen and carbon monoxide in the presence of a Group 8 to 10 metal-phosphine complex catalyst, including the following steps (1) and (2): (1) a step of oxidizing by withdrawing a reaction solution having accumulated therein a high-boiling-point byproduct from a reaction zone and bringing the withdrawn reaction solution into contact with an oxygen-containing gas, and (2) a step of, after the step (1), mixing a poor solvent and hydrogen with the reaction solution, then crystallizing the Group 8 to 10 metal-phosphine complex catalyst by crystallization, and recovering the crystallized complex catalyst from the reaction solution.

The present invention describes a process to isomerize industrial hemp derived Cannabidiol (CBD) to a pure Δ8-tetrahydrocannabinol (Δ8-THC) extract. This procedure will produce Δ8-tetrahydrocannabinol that is essentially free from any detectable levels of Δ9-tetrahydrocannabinol (Δ9-THC). Included in this filing are methods and processes to scale the reaction from the lab to process to large scale manufacturing. Additionally, the resulting extract from said methods and processes consists of higher purity than previously reported in the art and greater efficiency compared to prior art.

The present invention describes a process to isomerize industrial hemp derived Cannabidiol (CBD) to a pure Δ8-tetrahydrocannabinol (Δ8-THC) extract. This procedure will produce Δ8-tetrahydrocannabinol that is essentially free from any detectable levels of Δ9-tetrahydrocannabinol (Δ9-THC). Included in this filing are methods and processes to scale the reaction from the lab to process to large scale manufacturing. Additionally, the resulting extract from said methods and processes consists of higher purity than previously reported in the art and greater efficiency compared to prior art.

A method for separating trans isomer crocetin from cis isomer crocetin is provided. The method comprises crystallizing all-trans crocetin with calcium ions first by using different binding capabilities between cis and trans isomeric crocetin to calcium ions and acidifying the all-trans crocetin to obtain 13-cis crocetin.